Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
PL02a - Distinguished Lecture
- Type: Plenary
- Track:
- Presentations: 1
- Moderators:R. Pirker
- Coordinates: 12/05/2016, 08:45 - 09:00, Hall D (Plenary Hall)
-
+
Welcome Address
08:45 - 09:00 | Author(s): H. Fischer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ED01 - Biology of Lung Cancer
- Type: Education Session
- Track: Biology/Pathology
- Presentations: 4
- Moderators:R. Rosell
- Coordinates: 12/05/2016, 11:00 - 12:30, Hall C1
-
+
ED01.01 - Understanding Biology: The Road to Cure?
11:00 - 11:25 | Author(s): D.P. Carbone
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA04 - Epidemiology and Prevention of Lung Cancer
- Type: Oral Session
- Track: Epidemiology/Tobacco Control and Cessation/Prevention
- Presentations: 8
- Moderators:L. Petruželka
- Coordinates: 12/05/2016, 11:00 - 12:30, Schubert 4
-
+
OA04.05 - Chronic Inflammation, NSAIDS and the Risk of Lung Cancer Death (Abstract under Embargo until December 5, 7:00 CET)
11:45 - 11:55 | Author(s): M. Bittoni
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL03 - Presidential Symposium
- Type: Plenary
- Track:
- Presentations: 10
- Moderators:D.P. Carbone
- Coordinates: 12/06/2016, 08:35 - 10:25, Hall D (Plenary Hall)
-
+
PL03.01 - Presidential Address
08:35 - 08:45 | Author(s): D.P. Carbone
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.02 - Lung Cancer Staging – Changing the Clinical Practice
08:45 - 09:05 | Author(s): R. Rami-Porta
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.03 - Randomised Phase III Study of Osimertinib vs Platinum-Pemetrexed for EGFR T790M-Positive Advanced NSCLC (AURA3) (Abstract under Embargo until December 6, 7:00 CET)
09:05 - 09:15 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.04 - Discussant for PL03.02, PL03.03
09:15 - 09:25 | Author(s): T. Mitsudomi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.05 - BRAIN: A Phase Ⅲ Trial Comparing WBI and Chemotherapy with Icotinib in NSCLC with Brain Metastases Harboring EGFR Mutations (CTONG 1201) (Abstract under Embargo until December 6, 7:00 CET)
09:25 - 09:35 | Author(s): Y.-. Wu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.06 - Discussant for PL03.05
09:35 - 09:45 | Author(s): J. Jassem
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.07 - First-line Ceritinib Versus Chemotherapy in Patients With ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4) (Abstract under Embargo until December 6, 7:00 CET)
09:45 - 09:55 | Author(s): G. De Castro Jr
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.08 - Discussant for PL03.07
09:55 - 10:05 | Author(s): F. Blackhall
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.09 - Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2) (Abstract under Embargo until December 6, 7:00 CET)
10:05 - 10:15 | Author(s): R.N. Pillai
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL03.10 - Discussant for PL03.09
10:15 - 10:25 | Author(s): D.R. Gandara
- Abstract
No abstract available for this presentation
-
+
P2.01 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Biology/Pathology
- Presentations: 94
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.01-092 - PRMT5 is a Poor Prognostic Marker for NSCLC and Inhibition of PRMT5 Results in Increased Lung Cancer Sensitivity to Cisplatin and Radiotherapy
14:30 - 14:30 | Author(s): M.X. Welliver
- Abstract
Loading...
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-069 - LKB1 Loss is a Novel Determinant of MEK Sensitivity Due to Alterations in AKT/FOXO3 Signaling
14:30 - 14:30 | Author(s): T. Yamada
- Abstract
Loading... -
+
P2.03b-082 - AQP11 as a Novel Factor of Lung Cancer Cell Resistance to Cisplatin
14:30 - 14:30 | Author(s): J. Evans
- Abstract
Loading...
-
+
P2.04 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 54
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.04-027 - Targeting Adenosine A2B Receptor for Modulation of Tumor Microenvironment, Primary Tumor Growth, and Lung Metastasis
14:30 - 14:30 | Author(s): J. Evans
- Abstract
Loading...
-
+
P2.06 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Scientific Co-Operation/Research Groups (Clinical Trials in Progress should be submitted in this category)
- Presentations: 47
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.06-019 - A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): D. Owen
- Abstract
Loading...
-
+
ISS12 - Immuno–Oncology: A Renaissance in the Treatment of Lung Cancer – MSD Oncology
- Type: Industry Supported Symposium
- Track:
- Presentations: 7
- Moderators:D.P. Carbone
- Coordinates: 12/07/2016, 12:45 - 14:15, Lehar 3-4
-
+
ISS12.01 - Welcome and Opening Remarks
12:45 - 12:50 | Author(s): D.P. Carbone
- Abstract
No abstract available for this presentation
-
+
ISS12.02 - Immunotherapy Experience in Lung Cancer
12:50 - 13:05 | Author(s): N. Rizvi
- Abstract
No abstract available for this presentation
-
+
ISS12.03 - The Value of OD-L1 Expression in NSCLC
13:05 - 13:20 | Author(s): K. Kerr
- Abstract
No abstract available for this presentation
-
+
ISS12.04 - Patient Management
13:20 - 13:35 | Author(s): T. Newsom-Davis
- Abstract
No abstract available for this presentation
-
+
ISS12.05 - Lung Cancer Landscape: Future Directions
13:35 - 13:50 | Author(s): D.P. Carbone
- Abstract
No abstract available for this presentation
-
+
ISS12.06 - Panel Discussion
13:50 - 14:15
- Abstract
No abstract available for this presentation
-
+
ISS12.07 - Closing Remarks
14:15 - 14:15 | Author(s): D.P. Carbone
- Abstract
No abstract available for this presentation
-
+
MA16 - Novel Strategies in Targeted Therapy
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:G. Purkalne
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
-
+
MA16.03 - Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers
14:26 - 14:32 | Author(s): O. Gautschi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
